title: Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.
abstract: The retinoid X receptor (RXR) is essential as a common heterodimerization partner of several nuclear receptors (NRs). However, its function as a bona fide receptor for endogenous ligands has remained poorly understood. Such a role would depend on the existence of RXR activating ligands in vivo and on the ability of such ligands to influence relevant biological functions. Here we demonstrate the presence of endogenous RXR ligands in the embryonic central nervous system (CNS) and show that they can activate heterodimers formed between RXR and the orphan NR Nurr1 in vivo. Moreover, RXR ligands increase the number of surviving dopaminergic cells and other neurons in a process mediated by Nurr1-RXR heterodimers. These results provide evidence for a role of Nurr1 as a ligand-independent partner of RXR in its function as a bona fide ligand-activated NR. Finally, our findings identify RXR-Nurr1 heterodimers as a potential target in the treatment of neurodegenerative disease.
authors.affiliation: The Ludwig Institute for Cancer Research, Stockholm Branch, S-171 77 Stockholm, Sweden.
authors.forename: Asa
authors.initials: A
authors.lastname: Wallen-Mackenzie
authors.forename: Alexander
authors.initials: A
authors.lastname: Mata de Urquiza
authors.forename: Susanna
authors.initials: S
authors.lastname: Petersson
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Rodriguez
authors.forename: Stina
authors.initials: S
authors.lastname: Friling
authors.forename: Joseph
authors.initials: J
authors.lastname: Wagner
authors.forename: Peter
authors.initials: P
authors.lastname: Ordentlich
authors.forename: Johan
authors.initials: J
authors.lastname: Lengqvist
authors.forename: Richard A
authors.initials: RA
authors.lastname: Heyman
authors.forename: Ernest
authors.initials: E
authors.lastname: Arenas
authors.forename: Thomas
authors.initials: T
authors.lastname: Perlmann
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D001921:Brain / Q000196:embryology*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002822:Choriocarcinoma / Q000378:metabolism / Q000473:pathology; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D015259:Dopamine Agents / Q000494:pharmacology; D005260:Female; D005656:Fungal Proteins; D008024:Ligands; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008822:Mice, Transgenic; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D009930:Organic Chemicals; D051381:Rats; D018168:Receptors, Retinoic Acid / Q000235:genetics / Q000378:metabolism*; D047488:Retinoid X Receptors; D015398:Signal Transduction / Q000502:physiology*; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D014212:Tretinoin / Q000494:pharmacology
chemical_list: D000924:Anticholesteremic Agents; D000970:Antineoplastic Agents; D004268:DNA-Binding Proteins; D015259:Dopamine Agents; D005656:Fungal Proteins; C423914:LG 268; D008024:Ligands; C539883:Nr4a2 protein, mouse; C539884:Nr4a2 protein, rat; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D009930:Organic Chemicals; D018168:Receptors, Retinoic Acid; D047488:Retinoid X Receptors; D014157:Transcription Factors; D014212:Tretinoin